Evento
Classic histamine H1 receptors inverse agonists activate ERK1/2 pathway and modulate the transcription of pro-inflammatory genes
Burghi, Valeria
; Zappia, Carlos Daniel
; Ripoll, Sonia
; Echeverría, Emiliana Beatriz
; Shayo, Carina Claudia
; Monczor, Federico
; Fernandez, Natalia Cristina
Tipo del evento:
Reunión
Nombre del evento:
LXIV Reunión Anual de la Sociedad Argentina de Investigación Clínica; LI Reunión Anual de la Asociación Argentina de Farmacología Experimental; XXI Reunión Anual de la Sociedad Argentina de Biología; XXXI Reunión Anual de la Sociedad Argentina de Protozoología; IX Reunión Anual de la Asociación Argentina de Nanomedicinas y VI Reunión Científica Regional de la Asociación Argentina de Ciencia y Tecnología de Animales de Laboratorio
Fecha del evento:
13/11/2019
Institución Organizadora:
Sociedad Argentina de Investigación Clínica;
Asociación Argentina de Farmacología Experimenta;
Sociedad Argentina de Biología;
Sociedad Argentina de Protozoología;
Asociación Argentina de Ciencia y Tecnología de Animales de Laboratorio;
Asociación Argentina de Nanomedicinas;
Título de la revista:
Medicina (Buenos Aires)
Editorial:
Fundación Revista Medicina
ISSN:
0025-7680
Idioma:
Inglés
Clasificación temática:
Resumen
Recently, we showed that widely used histamine H1 receptor (H1R) ligands that exert therapeutic actions by blocking the effects of histamine (HA), display positive efficacy concerning receptor desensitization and/or internalization. Now we aimed to investigate whether these processes affect the modulation of pro-inflammatory genes and its relationship with the activation of other signaling pathways independent from G protein. While 3 h (long term) exposure to antihistamines decreased expression of pro-inflammatory genes, when we exposed A549 cells, endogenously expressing H1R to HA, chlorpheniramine (CHLOR) or diphenhydramine (DIPH) for 10 min and ligands were removed, ciclooxigenase 2 (COX-2) and interleukin 8 (IL-8) mRNA levels were increased after 2 h 50 min (among 40 and 100% for all ligands, P<0.05). Consistently, ERK1/2 phosphorylation levels were increased by HA (373±102%), CHLOR (95±30%) and DIPH (56±16%), P<0.05, indicating that they display positive efficacy towards this signaling pathway, that has been described to be involved in regulation of both genes. When A549 cells were pre-exposed for 3 h with these ligands, and after 1 h recovery, were stimulated with HA for 10 min, we found lower COX-2 mRNA levels compared to those observed without pretreatment (HA 29.5±0.5%, CHLOR 40.5±16.5 and DIPH 34±8.8% of reduction, P<0.05). We also found lower IL-8 mRNA levels in CHLOR and DIPH pretreated samples (both around 20% of reduction, P<0.05) although no differences were observed in HA pretreated cells. Thus, although short term exposure to antihistamines increase pro-inflammatory genes expression, a prolonged exposure with these ligands diminished it and impaired the increase induced by HA indicating that their anti-inflammatory effects continue despite the ligands being removed. In all, these findings reinforce the biased nature of these ligands and claim for a correct classification, providing evidence for a more rational and safe use of antihistamines.
Palabras clave:
biased agonism
,
antihistamines
,
cell signalling
Archivos asociados
Licencia
Identificadores
Colecciones
Eventos(IBYME)
Eventos de INST.DE BIOLOGIA Y MEDICINA EXPERIMENTAL (I)
Eventos de INST.DE BIOLOGIA Y MEDICINA EXPERIMENTAL (I)
Eventos(ININFA)
Eventos de INST.DE INVEST.FARMACOLOGICAS (I)
Eventos de INST.DE INVEST.FARMACOLOGICAS (I)
Citación
Classic histamine H1 receptors inverse agonists activate ERK1/2 pathway and modulate the transcription of pro-inflammatory genes; LXIV Reunión Anual de la Sociedad Argentina de Investigación Clínica; LI Reunión Anual de la Asociación Argentina de Farmacología Experimental; XXI Reunión Anual de la Sociedad Argentina de Biología; XXXI Reunión Anual de la Sociedad Argentina de Protozoología; IX Reunión Anual de la Asociación Argentina de Nanomedicinas y VI Reunión Científica Regional de la Asociación Argentina de Ciencia y Tecnología de Animales de Laboratorio; Mar del Plata; Argentina; 2019; 1-1
Compartir